stockrow
Saturday 7 November 2026
Export LIANY’s income statement to Excel — free account
LianBio Sponsored ADR
LIANY Healthcare Biotechnology
0.04
0.00
0.00%
Follow LIANY
Alert me
LianBio Sponsored ADR (LIANY) P/E ratio
As of 2 November 2026, LianBio Sponsored ADR (LIANY) trades at a P/E ratio of 0.0×. Over the past ten years it has ranged from 0.0× (December 2023) to 1.7× (March 2024); the current reading is higher than 45% of that period. That is below the Biotechnology industry median of 10.6× and below the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 1.7×
Ten-year median
0.0×
Current reading's percentile
45
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| VERU Veru Inc. compare | n/m |
| PTHS Pelthos Therapeutics Inc. compare | n/m |
| ALDX Aldeyra Therapeutics, Inc. compare | n/m |
| GRDX GridAI Technologies Corp. compare | n/m |
| INMB INmune Bio, Inc. compare | n/m |
| NNVC NanoViricides, Inc. compare | n/m |
| PMN Promis Neurosciences compare | n/m |
| TVGN Tevogen Inc. compare | n/m |
| LIANY LianBio Sponsored ADR | 0.0× |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)